Multiple Helicobacter pylori enzymes and cell envelope components (H. pylori)

Helicobacter pylori is a Gram-negative bacterium that colonizes the human stomach, causing chronic gastritis, peptic ulcers, and increasing the risk of gastric adenocarcinoma (StatPearls, 2023). The target Multiple Helicobacter pylori enzymes and cell envelope components encompasses the diverse molecular machinery required for the pathogen's survival in the acidic gastric environment and its subsequent pathogenesis. Key components include the enzyme urease, which facilitates acid neutralization, and various penicillin-binding proteins (PBPs) essential for cell wall integrity (PubMed, 2021). Additionally, cell envelope structures like lipopolysaccharides and outer membrane proteins are critical for host cell adhesion and immune system modulation (UniProt, 2024). Therapeutic strategies employ a multi-drug approach, using antibiotics such as clarithromycin and amoxicillin to inhibit protein and cell wall synthesis, respectively, alongside bismuth salts that exert direct bactericidal effects (NIH, 2022). Effective targeting of these bacterial components is the cornerstone of H. pylori eradication therapy, though rising antibiotic resistance presents a significant clinical challenge (WHO, 2020).

Other names

Helicobacter pyloriH. pylori componentsH. pylori enzymesH. pylori cell envelope

Inhibition of cell wall synthesis via penicillin-binding proteins, inhibition of protein synthesis via the 50S ribosomal subunit, inhibition of DNA replication via DNA gyrase, and direct bactericidal disruption of the cell membrane (NIH, 2022; PubMed, 2021).